Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Kraft Heinz Co (KHC) vs Neurocrine Biosciences Inc (NBIX) Price & Performance

Kraft Heinz CoTrade
Neurocrine Biosciences IncTrade

Price performance (Past 24H)

Key statistics

Kraft Heinz Co vs Neurocrine Biosciences Inc — how do they compare? Kraft Heinz Co trades at $24.66 (market cap $29.23B), while Neurocrine Biosciences Inc trades at $157.78 (market cap $16.46B). The key difference: Kraft Heinz Co is the larger of the two by market cap, and Kraft Heinz Co pays a 6.49% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.

KHCNBIX
Market Cap
$29.23B$16.46B
Sector
Consumer StaplesHealth
52-Week High
$28.06$185.50
52-Week Low
$21.21$123.10
Enterprise Value
$45.55B$16.48B
Dividend Yield
6.49%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Kraft Heinz Co

In July 2015, Kraft merged with Heinz to create the third-largest food and beverage manufacturer in North America behind PepsiCo and Nestle and the fifth-largest player in the world. Beyond its namesake brands, the combined firm's portfolio includes Oscar Mayer, Velveeta, and Philadelphia. Outside North America, the firm's global reach includes a distribution network in Europe and emerging markets that drive around one fifth of its consolidated sales base, as its products are sold in more than 190 countries and territories.

Read more on KHC

About Neurocrine Biosciences Inc

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.

Read more on NBIX